SBIO vs. AGNG ETF Comparison

Comparison of ALPS Medical Breakthroughs ETF (SBIO) to Global X Aging Population ETF (AGNG)

SBIO

ALPS Medical Breakthroughs ETF

SBIO Description

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$32.96

Average Daily Volume

13,667

Number of Holdings ^*

* may have additional holdings in another (foreign) market

AGNG

Global X Aging Population ETF

AGNG Description

The investment seeks results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index. The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.

Grade (RS Rating)

Last Trade

$30.33

Average Daily Volume

4,266

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	SBIO	AGNG
30 Days	-4.69%	0.26%
60 Days	-4.71%	3.44%
90 Days	-2.99%	2.85%
12 Months	6.55%	12.23%

6 Overlapping Holdings

Symbol	Grade	Weight in SBIO	Weight in AGNG	Overlap
ACAD	C	2.04%	0.27%	0.27%
AGIO	C	1.87%	0.4%	0.4%
ALEC	F	0.33%	0.2%	0.2%
DNLI	C	2.47%	0.33%	0.33%
MNKD	C	1.09%	0.34%	0.34%
TBPH	D	0.31%	0.27%	0.27%

SBIO Overweight 78 Positions Relative to AGNG

Symbol	Grade	Weight
KRYS	B	3.94%
ALKS	C	3.1%
MRUS	C	3.01%
RNA	C	2.93%
IMVT	D	2.87%
CRNX	D	2.59%
CORT	C	2.52%
FOLD	C	2.22%
ACLX	C	2.18%
XENE	F	2.13%
PTCT	D	2.01%
GERN	B	1.99%
IDYA	F	1.96%
CLDX	F	1.87%
VCEL	C	1.72%
NTLA	F	1.69%
CGON	D	1.52%
VERA	C	1.44%
PTGX	B	1.41%
ZLAB	F	1.35%
ARVN	F	1.33%
SNDX	C	1.3%
MORF	C	1.29%
GLPG	F	1.25%
IMCR	D	1.24%
KROS	F	1.23%
EWTX	B	1.23%
AKRO	C	1.22%
MIRM	B	1.18%
KURA	D	1.18%
RCUS	F	1.04%
BCRX	B	0.95%
VRNA	B	0.94%
DAWN	D	0.91%
XNCR	F	0.89%
IRON	C	0.83%
PRTA	F	0.83%
FDMT	D	0.82%
IRWD	F	0.74%
PHVS	F	0.73%
TARS	C	0.72%
LQDA	C	0.71%
VRDN	F	0.62%
AUPH	C	0.61%
COGT	C	0.61%
SPRY	C	0.59%
LBPH	B	0.57%
ETNB	F	0.56%
ANAB	B	0.51%
ARCT	F	0.5%
HLVX	C	0.5%
PLRX	F	0.49%
GHRS	D	0.47%
OLMA	D	0.47%
URGN	C	0.46%
ERAS	C	0.45%
FLGT	F	0.45%
MLYS	C	0.43%
CELC	B	0.43%
ITOS	D	0.42%
YMAB	D	0.41%
APLT	C	0.4%
SVRA	C	0.4%
REPL	C	0.39%
ALLO	F	0.38%
ALT	F	0.34%
ANNX	D	0.33%
CMPS	D	0.31%
ACIU	C	0.3%
FULC	F	0.29%
AURA	F	0.27%
AVXL	C	0.27%
VNDA	C	0.26%
ZNTL	F	0.23%
INZY	D	0.21%
ENTA	C	0.2%
STRO	F	0.18%
ALDX	F	0.15%

SBIO Underweight 43 Positions Relative to AGNG

Symbol	Grade	Weight
LLY	A	-3.49%
WELL	A	-3.43%
AMGN	B	-3.36%
REGN	B	-3.32%
BSX	B	-3.25%
AZN	C	-3.24%
EW	B	-2.92%
ABBV	C	-2.9%
JNJ	F	-2.87%
SYK	B	-2.82%
MDT	D	-2.75%
BMY	F	-2.41%
DXCM	D	-2.35%
ZBH	D	-1.92%
VTR	A	-1.84%
UTHR	B	-1.31%
PODD	C	-1.22%
NBIX	C	-1.21%
BGNE	F	-1.21%
INCY	D	-1.17%
DVA	C	-1.07%
TFX	C	-0.87%
OHI	B	-0.74%
EXAS	D	-0.69%
ENSG	B	-0.63%
BPMC	A	-0.6%
EXEL	C	-0.59%
HALO	B	-0.58%
GKOS	A	-0.52%
MMSI	B	-0.44%
SILK	B	-0.41%
NVCR	D	-0.35%
NHC	A	-0.35%
NHI	A	-0.34%
ITGR	C	-0.34%
EMBC	F	-0.32%
BKD	C	-0.32%
AGL	D	-0.32%
SBRA	A	-0.32%
LTC	A	-0.31%
AMED	A	-0.3%
LIVN	D	-0.28%
ATEC	D	-0.21%

SBIO: Top Represented Industries & Keywords

Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities